Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jul 8:3:19.
doi: 10.1186/1750-1172-3-19.

Abetalipoproteinemia: two case reports and literature review

Rola Zamel  1 , Razi Khan, Rebecca L Pollex, Robert A Hegele
Affiliations
Review

Abetalipoproteinemia: two case reports and literature review

Rola Zamel et al. Orphanet J Rare Dis. .

Abstract

Abetalipoproteinemia (ABL, OMIM 200100) is a rare, autosomal recessive disorder, characterized by fat malabsorption, acanthocytosis and hypocholesterolemia in infancy. Later in life, deficiency of fat-soluble vitamins is associated with development of atypical retinitis pigmentosa, coagulopathy, posterior column neuropathy and myopathy. ABL results from mutations in the gene encoding the large subunit of microsomal triglyceride transfer protein (MTP; OMIM 157147). To date at least 33 MTP mutations have been identified in 43 ABL patients. We describe the clinical progress of two patients, both currently in the fifth decade of life, who were diagnosed with ABL as children and were treated with high oral doses of fat soluble vitamins, including vitamin E over the last three decades. Treatment appears to have been associated with arrest of the neuropathy and other complications in both patients. Because pharmacologic inhibition of MTP is being developed as a novel approach to reduce plasma cholesterol for prevention of cardiovascular disease, defining the long-term clinical features of patients with a natural deficiency in MTP might provide some insight into the possible effects of such treatments. We review the range of clinical, biochemical and molecular perturbations in ABL.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Acanthocytes on the peripheral blood smear of case #1.
Figure 2
Figure 2
Genetic map of MTP mutations in patients with abetalipoproteinemia. The map shows the genomic structure of MTP gene. Black boxes represent exons; dotted lines point to mutation positions. Above the map are single-nucleotide and small insertion-deletion mutations. Nucleotide position in reference to the first ATG of MTP cDNA (GenBank Accession No. NM_000253) are shown. Directly under the linear map are splicing mutations. The position relative to the intron-exon boundary is shown numerically. Larger deletions are shown as horizontal lines below the linear map, with the span of the deleted region indicated by text label.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bassen FA, Kornzweig AL. Malformation of the erythrocytes in a case of atypical retinitis pigmentosa. Blood. 1950;5:381–387. - PubMed
    1. Sturman RM. The Bassen-Kornzweig syndrome: 18 years in evolution. J Mt Sinai Hosp N Y. 1968;35:489–517. - PubMed
    1. Lackner KJ, Monge JC, Gregg RE, Hoeg JM, Triche TJ, Law SW, Brewer HB., Jr Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia. J Clin Invest. 1986;78:1707–1712. doi: 10.1172/JCI112766. - DOI - PMC - PubMed
    1. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, Schmitz J, Gay G, Rader DJ, Gregg RE. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 1992;258:999–1001. doi: 10.1126/science.1439810. - DOI - PubMed
    1. Shoulders CC, Brett DJ, Bayliss JD, Narcisi TM, Jarmuz A, Grantham TT, Leoni PR, Bhattacharya S, Pease RJ, Cullen PM, et al. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum Mol Genet. 1993;2:2109–2116. doi: 10.1093/hmg/2.12.2109. - DOI - PubMed